MedTrace Logo

Anesthesia Methods on Percutaneous Kyphoplasty

NCT05526794 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 66

Last updated 2022-09-02

No results posted yet for this study

Summary

The aim of this research is to examine the effects of the anesthesia method and preoperative characteristics on postoperative results and complications in patients who underwent percutaneous kyphoplasty (PKP).

Method: Patients were split into three groups according to anesthesia methods: (1) General Anesthesia (Sedation), (2) Central Block (Spinal and Epidural Anesthesia), (3) Peripheral Block \[Erector Spina Plane Block (ESPB), and Paravertebral Block (PVB)\]. Patients' pain values, hemodynamic parameters, additional need for sedation, and perioperative and postoperative complications were recorded prospectively together with Visual Pain Scales (VAS).

Conditions

  • Vertebral Fracture

Interventions

PROCEDURE

Analgesic consumption

1 gr iv paracetamol for all patients with a VAS value of 2 or 3; for 4 and over, 1.5 mg/kg iv tramadol was administered additionally.

Sponsors & Collaborators

  • Bursa Yuksek Ihtisas Training and Research Hospital

    lead OTHER_GOV

Principal Investigators

  • Tuğba T Onur, MD · Bursa Yuksek Ihtisas Training and Research Hospital

  • Ümran Ü Karaca, MD · Bursa Yuksek Ihtisas Training and Research Hospital

  • Asiye A Demirel, MD · Bursa Yuksek Ihtisas Training and Research Hospital

  • Şeyda Efsun ŞE Özgünay, Assoc Prof · Bursa Yuksek Ihtisas Training and Research Hospital

  • Anıl A Onur, MD · Bursa Medicabil Hospital

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-01
Primary Completion
2022-07-01
Completion
2022-08-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05526794 on ClinicalTrials.gov